|
1
|
- Jonathan A. Fletcher, MD
- Dept of Pathology, Brigham & Women’s Hospital; Depts of Pediatric
and Adult Oncology, Dana-Farber Cancer Institute; Boston, MA
|
|
2
|
- GIST progenitor cell might be of the Interstitial cell of Cajal (ICC)
lineage. Atayde-Perez & Kozakewich AJSP 1993: “The tumor cells in
our patient and Cajal interstitial cells share certain common
ultrastructural features…. support an origin from the interstitial cells
of Cajal”
- ICC proliferation, as required for ICC to populate the GI tract, depends
on expression of the KIT receptor tyrosine kinase
|
|
3
|
- KIT gene encodes a 145 kD transmembrane receptor tyrosine kinase
- Belongs to a family that includes receptors for PDGF, M-CSF and flt3
ligand
- Important in normal hematopoiesis, melanogenesis, gametogenesis,
development of interstitial cells of Cajal, and mast cell
growth/differentiation
- Activation stimulates cell growth & survival, e.g. through the MAPK
and PI3K/AKT/mTOR signaling cascades
|
|
4
|
- Innervated network of KIT+ cells, associated with Auerbach’s plexus
- “Pacemaker” function coordinates peristalsis
|
|
5
|
|
|
6
|
|
|
7
|
|
|
8
|
|
|
9
|
|
|
10
|
- Familial GIST syndromes: germline KIT gain-of-function mutations and ICC
hyperplasia
- KIT mutations in incidental GISTS
- KIT mutations antedate cytogenetic aberrations
|
|
11
|
|
|
12
|
- “Benign” and “Malignant” GISTs are on a genetic continuum, progression
to malignancy being accompanied by acquisition of characteristic
cytogenetic deletions: -14, -22, 1p-, 9p-, 11p-
|
|
13
|
|
|
14
|
- Evidence for KIT activation as a central oncogenic mechanism in most
GISTs
- Developmental Biology (KIT role in ICC)
- Histopathology (GISTs arise from ICC lineage; KIT is expressed strongly
and diffusely in most GISTs)
- Cancer Biology (KIT gain-of-function mutations are found in most GISTs,
and antedate other known characteristic mutations)
- Cancer Genetics (initiating role of KIT gain-of-function mutation in
familial GIST syndromes)
|
|
15
|
|